Abstract
Objective: The aim of this study was to examine elastography-based prostate biopsy in prostate cancer (PCa) patients under active surveillance. Patients and Methods: We relied on PCa patients who opted for active surveillance and underwent elastography targeted and systematic follow-up biopsy at the Braunschweig Prostate Cancer Center between October 2009 and February 2015. Each prostate sextant was considered as an individual case. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy (ACC) for elastography to predict follow-up biopsy results were analyzed, respectively, and 95 % confidence intervals (CIs) were carried out by using 2000 bootstrapping sample analyses. Results: Overall, 50 men and 300 sextants were identified. Overall, 27 (54%) men and 66 (22%) sextants harbored PCa at follow-up biopsy. Sensitivity, specificity, PPV, NPV, and ACC for elastography to predict follow-up biopsy results were: 19.7 (95% CI: 11.9–27.3), 86.8 (95% CI: 82.7–90.3), 29.6 (95% CI: 14.6–46.0), 79.3 (95% CI: 71.6–86.5), and 72.0% (95% CI: 65.7–78.3), respectively. Conclusions: We recorded limited reliability of elastography-based prediction of follow-up biopsy results in active surveillance patients. Based on our analyses, we can neither recommend to rely exclusively on elastography-based targeted biopsies nor to delay or to omit follow-up biopsies based on elastography results during active surveillance.
References
1.
Klotz
L
, Vesprini
D
, Sethukavalan
P
, Jethava
V
, Zhang
L
, Jain
S
, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
. J Clin Oncol
. 2015
;33
(3
):272
–7
. 2.
Mottet
N
, Bellmunt
J
, Bolla
M
, Briers
E
, Cumberbatch
MG
, De Santis
M
, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
. Eur Urol
. 2017
;71
(4
):618
–29
. 3.
Schiffmann
J
, Manka
L
, Boehm
K
, Leyh-Bannurah
SR
, Karakiewicz
PI
, Graefen
M
, et al. Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer
. World J Urol
. 2015
;33
(12
):1993
–9
. 4.
Klotz
L
, Loblaw
A
, Sugar
L
, Moussa
M
, Berman
DM
, Van der Kwast
T
, et al. Active surveillance magnetic resonance imaging study (ASIST): results of a randomized multicenter prospective trial
. Eur Urol
. 2019
;75
(2
):300
–9
.5.
Boehm
K
, Budäus
L
, Tennstedt
P
, Beyer
B
, Schiffmann
J
, Larcher
A
, et al. Prediction of significant prostate cancer at prostate biopsy and per core detection rate of targeted and systematic biopsies using real-time shear wave elastography
. Urol Int
. 2015
;95
(2
):189
–96
. 6.
Salomon
G
, Drews
N
, Autier
P
, Beckmann
A
, Heinzer
H
, Hansen
J
, et al. Incremental detection rate of prostate cancer by HI-real time elastography targeted biopsies in combination to a conventional 10 core biopsy in 1024 consecutive men
. BJU Int
. 2014
;113
(4
):548
–53
.7.
Brock
M
, von Bodman
C
, Palisaar
RJ
, Löppenberg
B
, Sommerer
F
, Deix
T
, et al. The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: a prospective study of 353 patients
. J Urol
. 2012
;187
(6
):2039
–43
. 8.
Pallwein
L
, Mitterberger
M
, Pinggera
G
, Aigner
F
, Pedross
F
, Gradl
J
, et al. Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients
. Eur J Radiol
. 2008
;65
(2
):304
–10
. 9.
Heidenreich
A
, Bastian
PJ
, Bellmunt
J
, Bolla
M
, Joniau
S
, van der Kwast
T
, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013
. Eur Urol
. 2014
;65
(1
):124
–37
. 10.
Salomon
G
, Schiffmann
J
. Real-time elastography for the detection of prostate cancer
. Curr Urol Rep
. 2014
;15
(3
):392
. 11.
Ferrari
FS
, Scorzelli
A
, Megliola
A
, Drudi
FM
, Trovarelli
S
, Ponchietti
R
. Real-time elastography in the diagnosis of prostate tumor
. J Ultrasound
. 2009
;12
(1
):22
–31
. 12.
Giurgiu
CR
, Manea
C
, Crişan
N
, Bungărdean
C
, Coman
I
, Dudea
SM
. Real-time sonoelastography in the diagnosis of prostate cancer
. Med Ultrason
. 2011
;13
(1
):5
–9
.13.
König
K
, Scheipers
U
, Pesavento
A
, Lorenz
A
, Ermert
H
, Senge
T
. Initial experiences with real-time elastography guided biopsies of the prostate
. J Urol
. 2005
;174
(1
):115
–7
. 14.
Kamoi
K
, Okihara
K
, Ochiai
A
, Ukimura
O
, Mizutani
Y
, Kawauchi
A
, et al. The utility of transrectal real-time elastography in the diagnosis of prostate cancer
. Ultrasound Med Biol
. 2008
;34
(7
):1025
–32
. 15.
Nelson
ED
, Slotoroff
CB
, Gomella
LG
, Halpern
EJ
. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score
. Urology
. 2007
;70
(6
):1136
–40
. 16.
Aigner
F
, Pallwein
L
, Junker
D
, Schäfer
G
, Mikuz
G
, Pedross
F
, et al. Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less
. J Urol
. 2010
;184
(3
):913
–7
. 17.
Taverna
G
, Magnoni
P
, Giusti
G
, Seveso
M
, Benetti
A
, Hurle
R
, et al. Impact of real-time elastography versus systematic prostate biopsy method on cancer detection rate in men with a serum prostate-specific antigen between 2.5 and 10 ng/mL
. ISRN Oncol
. 2013
;2013
:584672
. 18.
Schiffmann
J
, Grindei
M
, Tian
Z
, Yassin
DJ
, Steinwender
T
, Leyh-Bannurah
SR
, et al. Limitations of elastography based prostate biopsy
. J Urol
. 2016
;195
(6
):1731
–6
. 19.
Zhang
Y
, Tang
J
, Li
YM
, Fei
X
, He
EH
, Li
QY
, et al. The contribution of strain patterns in characterization of prostate peripheral zone lesions at transrectal ultrasonography
. Acta Radiol
. 2012
;53
(1
):119
–26
. 20.
Carroll
PR
, Parsons
JK
, Andriole
G
, Bahnson
RR
, Barocas
DA
, Catalona
WJ
, et al. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines
. J Natl Compr Canc Netw
. 2014
;12
(9
):1211
–9
.21.
Schiffmann
J
, Tennstedt
P
, Fischer
J
, Tian
Z
, Beyer
B
, Boehm
K
, et al. Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate
. World J Urol
. 2014
;32
(4
):925
–30
. 22.
Barr
RG
, Memo
R
, Schaub
CR
. Shear wave ultrasound elastography of the prostate: initial results
. Ultrasound Q
. 2012
;28
(1
):13
–20
. 23.
Boehm
K
, Salomon
G
, Beyer
B
, Schiffmann
J
, Simonis
K
, Graefen
M
, et al. Shear wave elastography for localization of prostate cancer lesions and assessment of elasticity thresholds: implications for targeted biopsies and active surveillance protocols
. J Urol
. 2015
;193
(3
):794
–800
. 24.
Brock
M
, Löppenberg
B
, Roghmann
F
, Pelzer
A
, Dickmann
M
, Becker
W
, et al. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies
. J Urol
. 2015
;193
(4
):1191
–7
. 25.
Brock
M
, Eggert
T
, Palisaar
RJ
, Roghmann
F
, Braun
K
, Löppenberg
B
, et al. Multiparametric ultrasound of the prostate: adding contrast enhanced ultrasound to real-time elastography to detect histopathologically confirmed cancer
. J Urol
. 2013
;189
(1
):93
–8
. 26.
Schiffmann
J
, Connan
J
, Salomon
G
, Boehm
K
, Beyer
B
, Schlomm
T
, et al. Tumor volume in insignificant prostate cancer: increasing threshold gains increasing risk
. Prostate
. 2015
;75
(1
):45
–9
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
